The National Association of Chain Drug Stores (NACDS) and the University of Pittsburgh School of Pharmacy announce the availability of Test2LearnTM community-based pharmacogenomics certificate program and national tour. The program was adapted from a highly successful PittPharmacy program (www.test2Learn.org) and will include online home study and in-person live components, including an optional activity for learners to undergo personal genomic testing. Community pharmacist participants will engage in the in-person aspect of the program, as well as receive the instruction necessary to administer the training to others.
“Pharmacogenomics is considered a new frontier in patient care, with great promise for patient outcomes and public health, and the ‘train-the-trainer’ focus of the fall 2016 national tour will expand the knowledge of it exponentially”, said NACDS President and CEO Steven C. Anderson, IOM, CAE.
PittPharmacy Assistant Professor Philip Empey, PharmD, PhD, BCPS noted, “Participants who have learned using this model tell us it makes a meaningful impact in their education. Our published outcome data shows students are highly-engaged and achieved better learning outcomes. We are excited about offering this innovative certificate.”
Pharmacogenomics is a subset of the overarching concept of personalized medicine, which refers to ensuring that each patient receives the right medication and the right dose. Pharmacogenomics seeks to achieve that by predicting a response to a drug based on the individual’s genetic makeup.
Members of the Test2Learn team are Assistant Professor Philip E. Empey, PharmD, PhD, Associate Professor James Coons, PharmD, BCPS (AQ CV), Assistant Professor Lucas A Berenbrok, PharmD, Assistant Professor James M. Stevenson, PharmD, MS and PittPharmacy graduate student Solomon M. Adams, PharmD.
Learn more by visiting the Test2Learn web site.